277 related articles for article (PubMed ID: 26779657)
1. A role for spleen tyrosine kinase in renal fibrosis in the mouse obstructed kidney.
Ma FY; Blease K; Nikolic-Paterson DJ
Life Sci; 2016 Feb; 146():192-200. PubMed ID: 26779657
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of spleen tyrosine kinase (syk) suppresses renal fibrosis through anti-inflammatory effects and down regulation of the MAPK-p38 pathway.
Chen KH; Hsu HH; Yang HY; Tian YC; Ko YC; Yang CW; Hung CC
Int J Biochem Cell Biol; 2016 May; 74():135-44. PubMed ID: 26948651
[TBL] [Abstract][Full Text] [Related]
3. Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation.
Qu X; Zhang X; Yao J; Song J; Nikolic-Paterson DJ; Li J
J Pathol; 2012 Dec; 228(4):506-19. PubMed ID: 22610993
[TBL] [Abstract][Full Text] [Related]
4. Macrophage infiltration and renal damage are independent of matrix metalloproteinase 12 in the obstructed kidney.
Abraham AP; Ma FY; Mulley WR; Ozols E; Nikolic-Paterson DJ
Nephrology (Carlton); 2012 May; 17(4):322-9. PubMed ID: 22257277
[TBL] [Abstract][Full Text] [Related]
5. ASK1/p38 signaling in renal tubular epithelial cells promotes renal fibrosis in the mouse obstructed kidney.
Ma FY; Tesch GH; Nikolic-Paterson DJ
Am J Physiol Renal Physiol; 2014 Dec; 307(11):F1263-73. PubMed ID: 25298527
[TBL] [Abstract][Full Text] [Related]
6. Spleen tyrosine kinase contributes to acute renal allograft rejection in the rat.
Ramessur Chandran S; Tesch GH; Han Y; Woodman N; Mulley WR; Kanellis J; Blease K; Ma FY; Nikolic-Paterson DJ
Int J Exp Pathol; 2015 Feb; 96(1):54-62. PubMed ID: 25529862
[TBL] [Abstract][Full Text] [Related]
7. Protease-activated receptor 2 does not contribute to renal inflammation or fibrosis in the obstructed kidney.
Ma FY; Han Y; Ozols E; Chew P; Vesey DA; Gobe GC; Morais C; Lohman RJ; Suen JY; Johnson DW; Fairlie DP; Nikolic-Paterson DJ
Nephrology (Carlton); 2019 Sep; 24(9):983-991. PubMed ID: 31314137
[TBL] [Abstract][Full Text] [Related]
8. Extracellular signal-regulated kinase-dependent interstitial macrophage proliferation in the obstructed mouse kidney.
Han Y; Masaki T; Hurst LA; Ikezumi Y; Trzaskos JM; Atkins RC; Nikolic-Paterson DJ
Nephrology (Carlton); 2008 Oct; 13(5):411-8. PubMed ID: 18331439
[TBL] [Abstract][Full Text] [Related]
9. Targeting renal macrophage accumulation via c-fms kinase reduces tubular apoptosis but fails to modify progressive fibrosis in the obstructed rat kidney.
Ma FY; Liu J; Kitching AR; Manthey CL; Nikolic-Paterson DJ
Am J Physiol Renal Physiol; 2009 Jan; 296(1):F177-85. PubMed ID: 18987110
[TBL] [Abstract][Full Text] [Related]
10. Cyclophilin D promotes tubular cell damage and the development of interstitial fibrosis in the obstructed kidney.
Hou W; Leong KG; Ozols E; Tesch GH; Nikolic-Paterson DJ; Ma FY
Clin Exp Pharmacol Physiol; 2018 Mar; 45(3):250-260. PubMed ID: 29230844
[TBL] [Abstract][Full Text] [Related]
11. TGF-β1-activated kinase-1 regulates inflammation and fibrosis in the obstructed kidney.
Ma FY; Tesch GH; Ozols E; Xie M; Schneider MD; Nikolic-Paterson DJ
Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1410-21. PubMed ID: 21367917
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of fasudil on renal interstitial fibrosis induced by unilateral ureteral obstruction.
Baba I; Egi Y; Utsumi H; Kakimoto T; Suzuki K
Mol Med Rep; 2015 Dec; 12(6):8010-20. PubMed ID: 26498136
[TBL] [Abstract][Full Text] [Related]
13. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy.
Moon JA; Kim HT; Cho IS; Sheen YY; Kim DK
Kidney Int; 2006 Oct; 70(7):1234-43. PubMed ID: 16929250
[TBL] [Abstract][Full Text] [Related]
14. Semicarbazide-sensitive amine oxidase (SSAO) inhibition ameliorates kidney fibrosis in a unilateral ureteral obstruction murine model.
Wong M; Saad S; Zhang J; Gross S; Jarolimek W; Schilter H; Chen JA; Gill AJ; Pollock CA; Wong MG
Am J Physiol Renal Physiol; 2014 Oct; 307(8):F908-16. PubMed ID: 25143459
[TBL] [Abstract][Full Text] [Related]
15. Dihydroartemisinin attenuates renal fibrosis through regulation of fibroblast proliferation and differentiation.
Zhang B; Liu P; Zhou Y; Chen Z; He Y; Mo M; Dai G; Xia W; Du Y; Liu Y; Chen X
Life Sci; 2019 Apr; 223():29-37. PubMed ID: 30862567
[TBL] [Abstract][Full Text] [Related]
16. Myeloid cell-mediated renal injury in rapidly progressive glomerulonephritis depends upon spleen tyrosine kinase.
Ryan J; Ma FY; Han Y; Ozols E; Kanellis J; Tesch GH; Nikolic-Paterson DJ
J Pathol; 2016 Jan; 238(1):10-20. PubMed ID: 26251216
[TBL] [Abstract][Full Text] [Related]
17. 3-Bromopyruvate decreased kidney fibrosis and fibroblast activation by suppressing aerobic glycolysis in unilateral ureteral obstruction mice model.
Yu H; Zhu J; Chang L; Liang C; Li X; Wang W
Life Sci; 2021 May; 272():119206. PubMed ID: 33577854
[TBL] [Abstract][Full Text] [Related]
18. Spleen tyrosine kinase (Syk) inhibitor fostamatinib limits tissue damage and fibrosis in a bleomycin-induced scleroderma mouse model.
Pamuk ON; Can G; Ayvaz S; Karaca T; Pamuk GE; Demirtas S; Tsokos GC
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S15-22. PubMed ID: 26148346
[TBL] [Abstract][Full Text] [Related]
19. Endogenous relaxin is a naturally occurring modulator of experimental renal tubulointerstitial fibrosis.
Hewitson TD; Mookerjee I; Masterson R; Zhao C; Tregear GW; Becker GJ; Samuel CS
Endocrinology; 2007 Feb; 148(2):660-9. PubMed ID: 17095590
[TBL] [Abstract][Full Text] [Related]
20. Nintedanib, a triple tyrosine kinase inhibitor, attenuates renal fibrosis in chronic kidney disease.
Liu F; Wang L; Qi H; Wang J; Wang Y; Jiang W; Xu L; Liu N; Zhuang S
Clin Sci (Lond); 2017 Aug; 131(16):2125-2143. PubMed ID: 28646122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
